|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||
|
|||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sA577C10E-6021-11EF-825F-C56085CE164B&I=39IZM&T=&OP=Display&O=html&O1=15860074&O2=954925462143&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DIn%2520vitro%2520characterization%2520and%2520pharmacokinetics%2520of%2520dapagliflozin%2520%2528BMS-512148%2529%252C%2520a%2520potent%2520sodium-glucose%2520cotransporter%2520type%2520II%2520inhibitor%252C%2520in%2520animals%2520and%2520humans%26rft.au%3DObermeier%252C%2520M%26rft.date%3D2010-03-01%26rft.eissn%3D1521-009X%26rft.externalDocID%3D19996149%26rft.genre%3Darticle%26rft.issue%3D3%26rft.jtitle%3DDrug%2520metabolism%2520and%2520disposition%26rft.spage%3D405%26rft.volume%3D38%26rft_id%3Dinfo%253Adoi%252F10.1124%252Fdmd.109.029165%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MISCELLANEOUS_FREE_EJOURNALS-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-NCBI_PUBMED_FREE-getAbstract-object,6-ISI_WEB_OF_SCIENCE-getAuthor-object,7-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,8-REFWORKS_EXPORT_TOOL-getReference-object,9-SHERPA_RoMEO_LCL-getWebService-object,10-GOOGLE_SCHOLAR_FREE-getWebSearch-object,11-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.262186&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15860074-sA577C10E-6021-11EF-825F-C56085CE164B" timestamp="2024-08-22T02:58:41Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925462143</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans</jnl:atitle>
<jnl:jtitle>Drug Metabolism and Disposition</jnl:jtitle>
<jnl:date>2010-03-17</jnl:date>
<jnl:spage>405</jnl:spage>
<jnl:epage>414</jnl:epage>
<jnl:coden>DMDSAI</jnl:coden>
<jnl:issn>0090-9556</jnl:issn>
<jnl:volume>38</jnl:volume>
<jnl:issue>3</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1521-009X</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>DMDSAI</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:c493267bdfd6d0bb0da1ee0dd59647e648e9a545</ctx:identifier>
<ctx:identifier>urn:UUID:sA577C10E-6021-11EF-825F-C56085CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)